Prajwal Drugs Private Limited - Company Profile

It is a business services private limited company based in Delhi, Delhi, India, established in 2007.
2007 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Prajwal Drugs Private Limited

Prajwal Drugs Private Limited, a struck off private limited company, was established on 28 February 2007 in Delhi, Delhi, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999DL2007PTC159907. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M.

It upholds a active non-compliant status. Its leadership includes Namrata Arora (Director), Praveen Kumar (Director). It holds no open charges and ₹6.00 M settled loans. It is based at 21, First Floor, Vigyan Lok Shreshtha Vihar, Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999DL2007PTC159907

  • Registration Number

    159907

  • Incorporation Date

    28 February 2007

  • Authorized Capital

    ₹1.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Company Age 18 Year, 11 Months
  • Satisfied Charges ₹ 6.00 M
Company report

Prajwal Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Prajwal Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Prajwal Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Namrata Arora Director 28 Feb 2007 Current
Praveen Kumar Director 28 Feb 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Prajwal Drugs.

Enhance accessibility to Prajwal Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Prajwal Drugs revenue growth over time
Prajwal Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Prajwal Drugs?

Unlock access to Prajwal Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹6,000,000.00

Charges Breakdown by Lending Institutions
  • Syndicate Bank : 0.60 Cr
Latest Charge Details
Date Lender Amount Status
27 May 2008 Syndicate Bank ₹6.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Prajwal Drugs?

Unlock and access historical data on people associated with Prajwal Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Prajwal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prajwal Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Prajwal Drugs
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 27 May 2008 via Charge ID 10104264 with Syndicate Bank was fully satisfied on 27 May 2019. was documented.

  • Charges

    Progress on A charge with Syndicate Bank of Rs. 6.00 M registered on 27 May 2008 with Charge ID 10104264 was modified on 21 Mar 2009. was documented.

  • Charges

    A charge with Syndicate Bank amounted to Rs. 6.00 M with Charge ID 10104264 was registered on 27 May 2008. was recorded as a recent event.

  • Director Appointment

    Namrata Arora was appointed as a Director was appointed as a Director on 28 Feb 2007 & has been associated with this company since 18 years 11 months . was recorded as a recent event.

  • Director Appointment

    Progress on Praveen Kumar was appointed as a Director was appointed as a Director on 28 Feb 2007 & has been associated with this company since 18 years 11 months . was documented.

  • Company Incorporation

    Progress on Prajwal Drugs Private Limited was registered on 28 Feb 2007 with Roc Delhi & aged 18 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Prajwal Drugs Private Limited?

The CIN of Prajwal Drugs Private Limited is U74999DL2007PTC159907.

Where is Prajwal Drugs Private Limited headquartered?

Prajwal Drugs Private Limited is headquartered at 21, First Floor, Vigyan Lok Shreshtha Vihar, Delhi, Delhi, 110092.

When was Prajwal Drugs Private Limited incorporated?

Prajwal Drugs Private Limited was incorporated on 28 February 2007.

Who are the current directors of Prajwal Drugs Private Limited?

The current directors of Prajwal Drugs Private Limited are

What is the primary industry of Prajwal Drugs Private Limited?

The primary industry of Prajwal Drugs Private Limited is Business Services.

Is Prajwal Drugs Private Limited a listed company?

Prajwal Drugs Private Limited is unlisted.

What is the compliance status of Prajwal Drugs Private Limited?

The compliance status of Prajwal Drugs Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available